The goal is to improve the diagnosis of patients with FH by educating physicians and patients on Genetic Testing in FH, with 5 educational objectives:
1. Genetic origin of FH
2. Genetic testing and FH
3. Clinical use of Genetic Testing to screen FH patients
4. Implementation of cascade screening in clinical practice
5. Education for patients
Audience: specialists diagnosing and treating patients with FH (cardiologists and lipidologists). Additional resources will be developed to support patients and their families.
Methods: a free online CME-accredited e-learning with dissemination through IAS and its affiliate societies. Supported by educational material for patients and their families.
Assessment: within the e-learning an immediate evaluation of the participant’s understanding, together with a comprehensive overview of the outcomes of the educational programme: number of participants entering, number of completions, breakdown by country, results of the assessments etc.
National data on the frequency of genetic testing in FH will provide a baseline measurement.
In two or more regional centres the use of the genetic testing and the diagnosis-rate of FH will be measured over a certain period of time. All involved staff-members will be educated through the e-learning. The use of genetic testing and FH diagnosis-rate over this period will be measured.
The full comprehensive project will include needs analysis and outcomes assessment. COR2ED and the Scientific Directors are committed to obtain additional funding to conduct the scientifically valid outcomes measurement.